Clinical Trials Browser

Phase 2 × G(M1) Ganglioside × Clear all

NCT02093910 2014-11-19

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Phase 2 Unknown

Multiple Myeloma, Peripheral Nervous System Diseases